EUVIMEDEUVIMED entdecken
Crossref

The common mechanism underlying Shuangxinfang’s amelioration of post-myocardial infarction depression: Targeting S100A9/NLRP3 to improve mitochondrial energetics

Wanli Ding, Jialin Shao, Weizhe Zhao, Jiqiu Hou, Yue Zhang, Zhiqi Sun, Xiang Liu, Junqing Wang, Chao Wang, Haibin Zhao

Phytomedicine · 2026-09 · 159 · 158477

DOI: 10.1016/j.phymed.2026.158477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Wanli Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: The DongFang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Myocardial Infarction, Calgranulin B, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Post-myocardial infarction (post-MI) depression is a common clinical complication affecting approximately 29-40% of post-MI patients, whose pathological mechanism remains incompletely understood. While Shuangxinfang (Psycho-cardiology formula, PCF) has demonstrated efficacy in treating post-MI depression, its specific underlying mechanism of action remains poorly understood. OBJECTIVE: This study seeks to elucidate the common pathological mechanisms underlying myocardial infarction and depression, as well as the therapeutic pathway by which PCF exerts its effects, through an integrated approach combining transcriptomics, cellular experiments, and animal studies. METHOD: Transcriptomic analysis was employed to identify the potential molecular pathways. Cellular models employing H9C2 cardiomyocytes and astrocytes were established and subjected to hypoxia/reoxygenation intervention and S100A9 overexpression plasmid transfection, respectively. A rat model of post-MI depression was established. To validate the key findings, the following analytical methods were employed in the present study: real-time quantitative PCR (qRT-PCR), Western blotting, immunofluorescence (IF), enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC), colorimetric assays, and transmission electron microscopy (TEM). RESULTS: Transcriptomic analysis revealed that PCF potentially targets S100A9, the NLRP3 inflammasome, and mitochondrial dysfunction. Both in vivo and in vitro experiments confirmed that PCF primarily inhibits S100A9, thereby reducing S100A9/NLRP3 inflammatory pathway factors (S100A9, NLRP3, Caspase-1, IL-18, and IL-1β) and ameliorating mitochondrial energy metabolism. These effects included enhanced activity of mitochondrial complexes I-V, elevated mitochondrial membrane potential, decreased mitochondrial permeability transition pore opening, improved mitochondrial ultrastructure, facilitated ADP-to-ATP conversion, and ultimately enhanced ATP production. CONCLUSION: S100A9/NLRP3 inflammasome-mediated mitochondrial energetic dysfunction may represent the common pathological mechanism linking post-MI cardiac dysfunction and depression, while simultaneously serving as a therapeutic pathway through which PCF exerts its therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalMyocardial InfarctionCalgranulin BNLR Family, Pyrin Domain-Containing 3 ProteinDepressionMitochondriaAnimalsRatsMaleRats, Sprague-DawleyMyocytes, CardiacEnergy MetabolismDisease Models, AnimalCell Line

Stichwörter der Autor:innen

Mitochondrial energy metabolismNOD-like receptor familyPost-myocardial infarction depressionPyrin domain-containing 3S100A9ShuangxinfangTraditional Chinese medicine

Substanzen

Drugs, Chinese HerbalCalgranulin BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratshuangxinfang

Autor:innen und Institutionen

  • The DongFang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China.
  • The First Affiliated Hospital of Baotou Medical College, Baotou 014016, China.
  • The DongFang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China. Electronic address: wztg68682025@163.com.
  • The DongFang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China. Electronic address: 1197086386@qq.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ding, W., Shao, J., Zhao, W., Hou, J., Zhang, Y., Sun, Z., Liu, X., Wang, J., Wang, C., & Zhao, H. (2026). The common mechanism underlying Shuangxinfang’s amelioration of post-myocardial infarction depression: Targeting S100A9/NLRP3 to improve mitochondrial energetics. Phytomedicine, 159, 158477. https://doi.org/10.1016/j.phymed.2026.158477

Vancouver

Ding W, Shao J, Zhao W, Hou J, Zhang Y, Sun Z, et al. The common mechanism underlying Shuangxinfang’s amelioration of post-myocardial infarction depression: Targeting S100A9/NLRP3 to improve mitochondrial energetics. Phytomedicine. 2026;159:158477. doi:10.1016/j.phymed.2026.158477

BibTeX
@article{Ding2026,
  author = {Ding, Wanli and Shao, Jialin and Zhao, Weizhe and Hou, Jiqiu and Zhang, Yue and Sun, Zhiqi and Liu, Xiang and Wang, Junqing and Wang, Chao and Zhao, Haibin},
  title = {The common mechanism underlying Shuangxinfang’s amelioration of post-myocardial infarction depression: Targeting S100A9/NLRP3 to improve mitochondrial energetics},
  journal = {Phytomedicine},
  year = {2026},
  volume = {159},
  pages = {158477},
  doi = {10.1016/j.phymed.2026.158477}
}
Kostenlos starten →